CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities:
Net income/(loss)	$ (4,297,249)	$ 1,846,384
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	16,665	12,874
Operating lease asset amortization	168,671	158,502
Amortization of debt discount	2,069,206	542,164
Loss on equity method investment	2
Warranty reserve		(463)
Gain on extinguishment of liabilities, net		(3,617,904)
Changes in operating assets and liabilities:
Accounts receivable	(512,004)	(12,100)
Inventories	(45,448)	(130,369)
Prepaid expenses and other current assets	(411,802)	(161,592)
Accounts payable	(41,565)	(96,691)
Related party payable		(103,334)
Operating lease liabilities	(157,479)	(140,105)
Accrued interest	15,107	5,413
Accrued expenses	403,816	(312,073)
Net cash used in operating activities	(2,792,080)	(2,009,294)
Investing Activities:
Contributions to equity method investment	(83,559)
Payments on purchase of assets	(57,451)
Patent activity costs	(308)
Net cash used in investing activities	(141,318)
Financing Activities:
Proceeds from issuance of stock		5,500,000
Net cash provided by financing activities		5,500,000
Net change in cash and cash equivalents	(2,933,398)	3,490,706
Cash and cash equivalents at beginning of period	5,961,760	167,725
Cash and cash equivalents at end of period	3,028,362	3,658,431
Non-Cash Transactions:
Non-cash conversions of preferred stock and convertible notes to equity	9,200,000	$ 5,800,000
Series 1A preferred stock conversion	$ 740